Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000245395 | SCV000320186 | uncertain significance | Cardiovascular phenotype | 2020-01-07 | criteria provided, single submitter | clinical testing | The p.R19261W variant (also known as c.57781C>T), located in coding exon 153 of the TTN gene, results from a C to T substitution at nucleotide position 57781. The arginine at codon 19261 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000643817 | SCV000765504 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764307 | SCV000895326 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001092228 | SCV001779116 | likely benign | not provided | 2020-09-21 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001092228 | SCV005413016 | uncertain significance | not provided | 2024-06-10 | criteria provided, single submitter | clinical testing |